CA1214467A - 1-(3-halo-2-pyridinyl)piperazine - Google Patents

1-(3-halo-2-pyridinyl)piperazine

Info

Publication number
CA1214467A
CA1214467A CA000403610A CA403610A CA1214467A CA 1214467 A CA1214467 A CA 1214467A CA 000403610 A CA000403610 A CA 000403610A CA 403610 A CA403610 A CA 403610A CA 1214467 A CA1214467 A CA 1214467A
Authority
CA
Canada
Prior art keywords
compound
halo
treatment
piperazine
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000403610A
Other languages
English (en)
French (fr)
Inventor
Walfred S. Saari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1214467A publication Critical patent/CA1214467A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA000403610A 1981-05-26 1982-05-25 1-(3-halo-2-pyridinyl)piperazine Expired CA1214467A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26712081A 1981-05-26 1981-05-26
US267,120 1981-05-26

Publications (1)

Publication Number Publication Date
CA1214467A true CA1214467A (en) 1986-11-25

Family

ID=23017399

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000403610A Expired CA1214467A (en) 1981-05-26 1982-05-25 1-(3-halo-2-pyridinyl)piperazine

Country Status (17)

Country Link
EP (1) EP0065757B1 (enExample)
JP (1) JPS6055068B2 (enExample)
AT (1) ATE11134T1 (enExample)
AU (1) AU547319B2 (enExample)
CA (1) CA1214467A (enExample)
DE (1) DE3261827D1 (enExample)
DK (1) DK234282A (enExample)
ES (4) ES8306740A1 (enExample)
FI (1) FI821739A7 (enExample)
GR (1) GR76413B (enExample)
IE (1) IE53035B1 (enExample)
IL (1) IL65802A (enExample)
NO (1) NO821730L (enExample)
NZ (1) NZ200642A (enExample)
PH (1) PH18686A (enExample)
PT (1) PT74926B (enExample)
ZA (1) ZA823611B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH056685U (ja) * 1991-07-09 1993-01-29 株式会社ユアサコーポレーシヨン 電池の艤装構造
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
CN101671297B (zh) * 2008-09-11 2012-05-09 上海药明康德新药开发有限公司 4-(3-碘-2-吡啶基)哌嗪类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773951A (en) * 1972-12-21 1973-11-20 Miles Lab Method of treating depression with 1-(2-pyridyl)piperazine
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines

Also Published As

Publication number Publication date
ES8403476A1 (es) 1984-03-16
PT74926B (en) 1985-05-16
PT74926A (en) 1982-06-01
PH18686A (en) 1985-08-29
NZ200642A (en) 1984-11-09
AU8380282A (en) 1982-12-02
ES512533A0 (es) 1983-06-01
FI821739A7 (fi) 1982-11-27
DE3261827D1 (en) 1985-02-21
ES8403475A1 (es) 1984-03-16
JPS584766A (ja) 1983-01-11
AU547319B2 (en) 1985-10-17
DK234282A (da) 1982-11-27
IE821225L (en) 1982-11-26
ATE11134T1 (de) 1985-01-15
GR76413B (enExample) 1984-08-10
ZA823611B (en) 1983-12-28
EP0065757B1 (en) 1985-01-09
IE53035B1 (en) 1988-05-11
EP0065757A1 (en) 1982-12-01
ES519855A0 (es) 1984-03-16
IL65802A (en) 1985-12-31
ES519856A0 (es) 1984-03-16
ES8306740A1 (es) 1983-06-01
ES8403477A1 (es) 1984-03-16
ES519854A0 (es) 1984-03-16
FI821739A0 (fi) 1982-05-17
JPS6055068B2 (ja) 1985-12-03
NO821730L (no) 1982-11-29
IL65802A0 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
US4426387A (en) Piperid-4-yl ureas and thio ureas used as anti-depressant agents
CA1214467A (en) 1-(3-halo-2-pyridinyl)piperazine
CZ287381B6 (en) Piperazine derivatives, processes and intermediates for their preparation, their use and pharmaceutical compositions based thereon
PL192397B1 (pl) Pochodna 1-(1,2-dipodstawionej piperydynylo)-4-piperydyny, jej zastosowanie, sposób wytwarzania i kompozycja farmaceutyczna
KR900005022B1 (ko) 1-(아미노알킬)-α, α-디아릴 피롤리딘-, 피페리딘- 및 호모피페리딘-아세트아미드 및 아세토니트릴, 및 이의 제조방법
DE3786118T2 (de) Aminoalkylthio-Triazolopyridin- oder Triazolochinolinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel, brauchbar als Antalgikum.
EP0029707B1 (en) Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
DE69414855T2 (de) N-(piperidinyl-1-alkyl)-substituierte cyclohexancarbonsäureamide als 5ht1a rezeptor antagonisten
JPS6123790B2 (enExample)
DE69031111T2 (de) Indolderivate
DE69007126T2 (de) Muscarin-rezeptor-antagonisten.
DE19747063A1 (de) 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung
EP0690845B1 (en) Piperazine derivatives as 5-ht1a ligands
IL273748A (en) Troueryl compounds as positive allosteric modulators for muscarinic m1 receptors
US4456604A (en) 1-(3-Halo-2-pyridinyl) piperazine
JP3306827B2 (ja) 新規ニコチン酸エステル
DE4032766A1 (de) Phenylpiperidinoylamine und diese enthaltende arzneimittel
GB2249093A (en) Piperidine derivatives and their use in pharmaceutical compositions
US4442103A (en) Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines
US6326371B1 (en) Pyrudyl and pyrimidylpiperazine derivatives
US4985438A (en) Pyridyl-and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
US4722930A (en) 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and derivatives
US3262936A (en) Ring substituted-1-cyanolower-alkylpiperidines
US3391143A (en) 9-piperidyl and 9-piperidylidene derivatives of acridan
CA1213586A (en) Substituted pyridopyridiminones

Legal Events

Date Code Title Description
MKEX Expiry